These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 34244223)

  • 1. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
    Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
    J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Krenning's score on 68 Ga-DOTATATE PET-CT and miPSMA score on 68 Ga-PSMA-11 PET-CT in TENIS: a comparison with FDG PET/CT and examining the feasibility of targeted radionuclide therapy.
    Sonavane S; Salvi O; Asopa RV; Basu S
    Nucl Med Commun; 2024 Aug; 45(8):690-701. PubMed ID: 38832433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for
    Uprimny C; Bayerschmidt S; Kroiss AS; Fritz J; Nilica B; Svirydenka H; Decristoforo C; von Guggenberg E; Horninger W; Virgolini IJ
    J Nucl Med; 2021 Nov; 62(11):1550-1557. PubMed ID: 33712533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of tumor sink effect: Insights from
    Tuncel M; Telli T; Tuncalı MÇ; Karabulut E
    Ann Nucl Med; 2021 May; 35(5):529-539. PubMed ID: 33586096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Visually Calculated SUV
    Swiha M; Papa N; Sabahi Z; Ayati N; John N; Pathmanandavel S; Crumbaker M; Li S; Agrawal S; Ayers M; Hickey A; Sharma S; Nguyen A; Emmett L
    J Nucl Med; 2024 Jun; 65(6):904-908. PubMed ID: 38637137
    [No Abstract]   [Full Text] [Related]  

  • 7. Eligibility for
    Cook GJR; Wong WL; Sanghera B; Mangar S; Challapalli A; Bahl A; Bassett P; Leaning D; Schmidkonz C
    J Nucl Med; 2023 Feb; 64(2):227-231. PubMed ID: 36302657
    [No Abstract]   [Full Text] [Related]  

  • 8. Examining Absorbed Doses of Indigenously Developed
    Kamaldeep ; Wanage G; Sahu SK; Maletha P; Adnan A; Suman S; Basu S; Das T; Banerjee S
    Cancer Biother Radiopharm; 2021 Apr; 36(3):292-304. PubMed ID: 32379495
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of Practical Interpretation Hurdles in 68Ga-PSMA PET/CT in 55 Patients: Physiological Tracer Distribution and Incidental Tracer Uptake.
    Kirchner J; Schaarschmidt BM; Sawicki LM; Heusch P; Hautzel H; Ermert J; Rabenalt R; Antoch G; Buchbender C
    Clin Nucl Med; 2017 Jul; 42(7):e322-e327. PubMed ID: 28481787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-Specific Membrane Antigen Radioligand Therapy Using
    Schuchardt C; Zhang J; Kulkarni HR; Chen X; Müller D; Baum RP
    J Nucl Med; 2022 Aug; 63(8):1199-1207. PubMed ID: 34887335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L
    Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Sink Effect in
    Gafita A; Wang H; Robertson A; Armstrong WR; Zaum R; Weber M; Yagubbayli F; Kratochwil C; Grogan TR; Nguyen K; Navarro F; Esfandiari R; Rauscher I; Menze B; Elashoff D; Delpassand ES; Herrmann K; Czernin J; Hofman MS; Calais J; Fendler WP; Eiber M
    J Nucl Med; 2022 Feb; 63(2):226-232. PubMed ID: 34049987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment
    Eisazadeh R; Mirshahvalad SA; Schwieghofer-Zwink G; Hehenwarter L; Rendl G; Gampenrieder S; Greil R; Pirich C; Beheshti M
    Mol Imaging Biol; 2024 Apr; 26(2):360-369. PubMed ID: 38360991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of [
    Groener D; Wichert J; Adams M; Mader N; Klimek K; Nguyen Ngoc C; Baumgarten J; Happel C; Mandel P; Chun FKH; Tselis N; Grünwald F; Sabet A
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
    Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
    Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial evaluation and external validation of 68Ga-PSMA-11 PET/CT in tubarial gland characterization.
    Alvarez-Lozada LA; Salinas-Puente EJ; Torres-De León RA; Arrambide-Garza FJ; Quiroga-Garza A; Elizondo-Riojas G; Elizondo-Omaña RE; Guzmán-López S; Treviño-Gonzalez JL
    Radiother Oncol; 2024 Jan; 190():109975. PubMed ID: 37913955
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Liu C; Liu T; Zhang Z; Zhang N; Du P; Yang Y; Liu Y; Yu W; Li N; Gorin MA; Rowe SP; Zhu H; Yan K; Yang Z
    J Nucl Med; 2020 Sep; 61(9):1314-1319. PubMed ID: 32034111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of uptake time on image quality of [
    van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
    Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between whole body volumetric parameters of
    Yildirim ÖA; Gündoğan C; Can C; Poyraz K; Erdur E; Kömek H
    Ann Nucl Med; 2021 May; 35(5):540-548. PubMed ID: 33586097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.